Prostate inflammation: Association with benign prostatic hyperplasia and prostate cancer

Saudi Medical Journal

Volumn 30, Issue 12, 2009, Pages 1563-1567

  Abdel Meguid, Taha A ^a   Mosli, Hisham A ^a   Al Maghrabi, Jaudah A ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATITIS; RETROSPECTIVE STUDY; SAUDI ARABIA; TRANSURETHRAL RESECTION; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROSTATITIS;

EID: 74749101783     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Delongchamps NB, de la Roza G, Chandan V, Jones R, Sunheimer R, Threatte G, et al. Evaluation of prostatitis in autopsied prostates-is chronic inflammation more associated with benign prostatic hyperplasia or cancer? J Urol 2008; 179: 1736-1740.
2. Lu Y, Cai Z, Galson DL, Xiao G, Liu Y, George DE et al. Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. Prostate 2006; 66: 1311-1318.
3. Dennis LK, Dawson DV. Meta-analysis of measures of sexual activity and prostate cancer. Epidemiology 2002; 13: 72-79.
4. Nickel JC. Inflammation and benign prostatic hyperplasia. Urol Clin North Am 2008; 35: 109-115. Review.
5. Nickel JC, Roehrborn CG, O'leary MP, Bostwick DG, Somerville MC, Rittmaster RS. Examination of the relationship between symptoms of prostatitis and histologic inflammation: baseline data from the REDUCE chemoprevention trial. J Urol 2007; 178: 896-901.
6. Lee KL, Peehl DM. Molecular and cellular pathogenesis of benign prostatic hyperplasia. J Urol 2004; 172: 1784-1791.
7. Untergasser G, Madersbacher S, Berger P. Benign prostatic hyperplasia: age-related tissue remodeling. Exp Gerontol 2005; 40: 121-128.
8. Kramer G, Marberger M. Could Inflammation be a key component in the progression of benign prostatic hyperplasia? Curr Opin Urol 2006; 16: 25-29.
9. MacLennan GT, Eisenberg R, Fleshman RL, Taylor M, Fu P, Resnick MI, et al. The influence of chronic inflammation in prostatic carcinogenesis: a 5-year follow up study. J Urol 2006; 176: 1012-1016.
10. Vasto S, Carruba G, Candore G, Italiano E, Di Bona D, Caruso C. Inflammation and prostate cancer. Future Oncol 2008; 4: 637-645.
11. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867.
12. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003; 3: 276-285.
13. Clark LC, Dalkin B, Krongrad A, Combs GF Jr, Turnbull BW, Slate EH, et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double blind cancer prevention trial. Br J Urol 1998; 81: 730-734.
14. Taylor ML, Mainous AG 3rd, Wells BJ. Prostate cancer and sexually transmitted diseases: a meta-analysis. Fam Med 2005; 37: 506-512.
15. Gerstenbluth RE, Seftel AD, MacLennan GT, Rao RN, Corty EW, Ferguson K, et al. Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of Bcl-2 in areas of inflammation. J Urol 2002; 167: 2267-2270.
16. Mosli HA. Prostate cancer in Saudi Arabia in 2002. Saudi Med J 2003; 24: 573-581.